(SPHDF)

$9.42 0.00 (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmon...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 61 906 89 50
Fax: 41 61 906 89 51
Address:
Hohenrainstrasse 24, Pratteln, Switzerland
Krzysiu
Krzysiu Dec. 30 at 12:06 PM
$SPHDF isn’t she a beauty? $30+ by Q1 2025
0 · Reply
Krzysiu
Krzysiu Aug. 9 at 11:58 AM
$SPHDF big ER coming I expect. Did yall see $CPRX #’s ? Royalty sales flowing by into Santhera pockets. Vamorolone sales numbers looking good. Santhera will be waking up really soon.
0 · Reply
fda_tracker
fda_tracker Mar. 4 at 2:05 PM
$SPHDF Phase 2 trial w/est Mar completion date NCT05185622: https://www.clinicaltrials.gov/study/NCT05185622 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
Sexychart
Sexychart Oct. 31 at 12:08 PM
$SRPT $SPHDF CH SANN - DMD FDA ✅️ LAST
0 · Reply
Gugger
Gugger Oct. 31 at 10:02 AM
$SPHDF Buying here, could be CHF 50 end of 2024 :-) or somebody (Roche) could buy it at that price before ?!
0 · Reply
Slobix
Slobix Oct. 30 at 6:54 AM
$CPRX $SPHDF Sell on good news.
0 · Reply
chop14
chop14 Oct. 27 at 10:26 PM
$SPHDF it s not flying like a rocket today 😵‍💫🤔 $CPRX. Strange ?!
0 · Reply
Kijoe
Kijoe Oct. 26 at 9:32 PM
$SPHDF lets go 💪🏼
0 · Reply
Slobix
Slobix Oct. 26 at 8:07 PM
$SPHDF Yesssss! FDA approved! $$$$$$$$$$$$$$$$$$$$$$$$$$ Rocket!
0 · Reply
Slobix
Slobix Oct. 23 at 12:08 PM
$LMDX $SPHDF is next.
0 · Reply
Latest News on SPHDF
No data available.
Krzysiu
Krzysiu Dec. 30 at 12:06 PM
$SPHDF isn’t she a beauty? $30+ by Q1 2025
0 · Reply
Krzysiu
Krzysiu Aug. 9 at 11:58 AM
$SPHDF big ER coming I expect. Did yall see $CPRX #’s ? Royalty sales flowing by into Santhera pockets. Vamorolone sales numbers looking good. Santhera will be waking up really soon.
0 · Reply
fda_tracker
fda_tracker Mar. 4 at 2:05 PM
$SPHDF Phase 2 trial w/est Mar completion date NCT05185622: https://www.clinicaltrials.gov/study/NCT05185622 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
Sexychart
Sexychart Oct. 31 at 12:08 PM
$SRPT $SPHDF CH SANN - DMD FDA ✅️ LAST
0 · Reply
Gugger
Gugger Oct. 31 at 10:02 AM
$SPHDF Buying here, could be CHF 50 end of 2024 :-) or somebody (Roche) could buy it at that price before ?!
0 · Reply
Slobix
Slobix Oct. 30 at 6:54 AM
$CPRX $SPHDF Sell on good news.
0 · Reply
chop14
chop14 Oct. 27 at 10:26 PM
$SPHDF it s not flying like a rocket today 😵‍💫🤔 $CPRX. Strange ?!
0 · Reply
Kijoe
Kijoe Oct. 26 at 9:32 PM
$SPHDF lets go 💪🏼
0 · Reply
Slobix
Slobix Oct. 26 at 8:07 PM
$SPHDF Yesssss! FDA approved! $$$$$$$$$$$$$$$$$$$$$$$$$$ Rocket!
0 · Reply
Slobix
Slobix Oct. 23 at 12:08 PM
$LMDX $SPHDF is next.
0 · Reply
Slobix
Slobix Oct. 23 at 12:00 PM
$SPHDF Hahahahaha! They need Shares! Todays chart is speaking.
0 · Reply
Slobix
Slobix Oct. 22 at 12:10 PM
$SPHDF Great Performance since 13.10.nearly 100% up. This will go to moon. Make you r DD. Swiss solid stock. No shares to borrow . Institutions try to geht in. 26.10. Boooom!
0 · Reply
aydin90
aydin90 Oct. 20 at 2:00 PM
$SPHDF Next week to the moon
0 · Reply
chop14
chop14 Oct. 16 at 9:51 AM
$SPHDF avec a look at Santhera on the Swiss stock market. 👍🏻 $PFE $JNJ $MRK $ABBV
0 · Reply
chop14
chop14 Oct. 13 at 8:51 AM
$LLY $PFE $JNJ $MRK HAVE A LOOK AT SANTHERA, Swiss exchange. $SPHDF
0 · Reply
hansimhaus
hansimhaus Oct. 7 at 1:19 PM
$SPHDF soooon..26.10.2023
0 · Reply